Best of September: Top 5 Insights In Drug Formulation and Delivery

#1 - Preparing For The FDA QMSR: Will You Be Ready?

The new FDA Quality Management System Regulation becomes effective in February 2026. In this article, Fran DeGrazio discusses the implications for combination product and medical device developers as they prepare to demonstrate QMSR compliance.

#2 - LNP-Delivered mRNA via Inhalation with Ethris' Carsten Rudolph and Thomas Langenickel

In this inaugural episode of In Combination, host Tom von Gunden combines the perspectives of two executives from LNP/mRNA (lipidoid nanoparticle / messenger RNA) formulation and delivery platform developer Ethris.

#3 - Are You Compliant? States Are Issuing New Regulations For IV Therapy Compounding

This article delves into the emerging regulations across various states and their potential impacts on professionals within the drug delivery sector, particularly those involved in drug formulation, IV pump manufacturing, and other related fields.

#4 - Rare Disease Targeting and Novel Therapy Delivery with Kymanox' Evan Edwards

Commenting on a wide range of therapeutic targets, Kymanox president Evan Edwards joins Supplier Horizons host Tom von Gunden in highlighting opportunities for drug delivery innovation.

#5 - Drug Product Formulation & Process Development: The Must-Have Skills At A Glance

Specialists in drug product formulation and process developmentat small biopharmas need to balance scientific knowledge and multidisciplinary know-how across the stages of product development. Explore the must-have skills.